Table 5 Pairwise statistical comparison of nonpolyalanine repeat expansion variants groupings.
Phenotype | Variant type | NMD | Non-NMD | MS |
|---|---|---|---|---|
Hypoventilation/apnea | NMD | 0.018 | - | |
Non-NMD | 0.018 | - | ||
MS | - | - | ||
Later-onset hypoventilation | NMD | 0.009 | - | |
Non-NMD | 0.009 | 0.015 | ||
MS | - | 0.015 | ||
24-hour artificial ventilation | NMD | <0.001 | - | |
Non-NMD | <0.001 | 0.014 | ||
MS | - | 0.014 | ||
Gastrointestinal symptoms | NMD | - | - | |
Non-NMD | - | 0.004 | ||
MS | - | 0.004 | ||
Hirschsprung disease (HSCR) | NMD | 0.05 | - | |
Non-NMD | 0.05 | 0.006 | ||
MS | - | 0.006 | ||
Long-segment aganglionosis HSCR | NMD | - | - | |
Non-NMD | - | 0.011 | ||
MS | - | 0.011 | ||
Neural crest tumors | NMD | - | - | |
Non-NMD | - | - | ||
MS | - | - | ||
Phenotype | Variant type | NMD | Non-NMD | MS |